Results 241 to 250 of about 150,375 (268)

Lewy Body Dementia Research in Latin America: A Scoping Review

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Dementia research in Latin America (LA) has primarily focused on Alzheimer's Disease and Frontotemporal Dementia, while Lewy body dementia (LBD) has been largely forgotten. Objective We aimed to review the available evidence on LBD in LA, offering a comprehensive perspective for understanding the lack of reports and the unique ...
Carlos Cano‐Gutiérrez   +31 more
wiley   +1 more source

Cyclodextrin-Based Drug Delivery Systems for Depression: Improving Antidepressant Bioavailability and Targeted Central Nervous System Delivery. [PDF]

open access: yesPharmaceutics
Văruț RM   +9 more
europepmc   +1 more source

Expert Consensus on the Diagnosis and Treatment of Malignant Pericardial Mesothelioma

open access: yesMed Research, EarlyView.
ABSTRACT Primary malignant pericardial mesothelioma (PMPM), a rare pericardium‐derived malignancy, urgently requires standardized diagnostic and therapeutic protocols. This consensus, established by the Chinese Alliance of Research for Mesothelioma (ChARM) through the integration of evidence‐based research and multicenter clinical expertise, addresses ...
Qing Ji   +112 more
wiley   +1 more source

Transcranial Temporal Interference Stimulation of the Right Globus Pallidus in Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Invasive deep brain stimulation (DBS) has been shown to be effective in treating patients with Parkinson's disease (PD), yet its clinical use is limited to patients at the advanced stage of the disease. Transcranial temporal interference stimulation (tTIS) may be a novel nonneurosurgical and safer alternative, yet its therapeutic ...
Chenhao Yang   +13 more
wiley   +1 more source

Interpersonal Psychotherapy for the Treatment of Depression in Parkinson's Disease: Results of a Randomized Controlled Trial

open access: yesMovement Disorders, EarlyView.
Abstract Background Depression is a common nonmotor complication in Parkinson's disease (PD). However, few studies have evaluated the efficacy of first‐line psychological therapies for depression in this patient population. Objectives This randomized controlled trial evaluated the efficacy of interpersonal psychotherapy (IPT), an empirically validated ...
Diana Koszycki   +5 more
wiley   +1 more source

Selective Effects of Substantia Nigra and Locus Coeruleus Degeneration on Cognition in Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background The substantia nigra (SN) and locus coeruleus (LC) are among the first brain regions to degenerate in Parkinson's disease (PD). This has important implications for early cognitive deficits because these nuclei are sources of ascending neuromodulators (i.e., dopamine and noradrenaline) that support various cognitive functions such as
Sophie Sun   +6 more
wiley   +1 more source

Pharmacological Mechanism and Drug Research Prospects of Ginsenoside Rb1 as an Antidepressant. [PDF]

open access: yesAntioxidants (Basel)
Zhuang S   +6 more
europepmc   +1 more source

Antidopaminergic Medications and Clinical Changes in Measures of Huntington's Disease: A Causal Analysis

open access: yesMovement Disorders, EarlyView.
Abstract Background Antidopaminergic medications (ADM) are often used for symptom management of Huntington's disease (HD). Evidence from past research suggests that ADMs are associated with worse clinical outcomes in HD, but their impact on various domains remains underexplored.
Michal Geva   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy